Clinical Trial Update: Hydroxychloroquine and Indapamide in SPMS [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating hydroxychloroquine and indapamide in secondary progressive multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis Secondary Progressive

Drugs mentioned

• Hydroxychloroquine (hydroxychloroquine)
• Indapamide (Indapamide)

Snippet

Sponsor: University of Calgary | Conditions: Multiple Sclerosis, Secondary Progressive | Phase 2 | Status: UNKNOWN